Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 13 November

Jessica Amir
November 13, 2020

Morning Bell 12 November

Jessica Amir
November 12, 2020

Morning Bell 11 November

Jessica Amir
November 11, 2020

Morning Bell 10 November

Jessica Amir
November 10, 2020

Morning Bell 9 November

Jessica Amir
November 9, 2020

Weekly Wrap 6 November

Jessica Amir
November 6, 2020

Morning Bell 6 November

Jessica Amir
November 6, 2020

Morning Bell 5 November

Jessica Amir
November 5, 2020

Morning Bell 4 November

Jessica Amir
November 4, 2020

Morning Bell 3 November

Jessica Amir
November 3, 2020

Morning Bell 2 November

Jessica Amir
November 2, 2020